Identification
- Composition (DCI)
- octocog alfa
- Manufacturer
- BAYER S.A
- ATC code
- B02BD02
- Presentation
- Seringue pré-remplie
- Schedule / Reimb.
- Aucun
- Hospital price
- 2228.00 MAD
Indications
Traitement et prophylaxie des hémorragies chez les patients de tous âges atteints d'hémophilie A (carence héréditaire en facteur VIII de la coagulation). Kovaltry ne contient pas de facteur de von Willebrand et n'est par conséquent pas adapté au traitement du syndrome de von Willebrand-Jürgens. Source : Compendium.ch - Date : 21 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About KOVALTRY 500 UI
KOVALTRY 500 UI is marketed in Morocco by BAYER S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of KOVALTRY 500 UI, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about KOVALTRY 500 UI
Answers to common questions from Moroccan patients about this drug.